{
    "ticker": "ZCMD",
    "name": "Zymeworks Inc.",
    "description": "Zymeworks Inc. is a clinical-stage biopharmaceutical company dedicated to the development of multifunctional therapeutics for the treatment of cancer and other serious diseases. Founded in 2003 and headquartered in Vancouver, Canada, Zymeworks leverages its proprietary ZymeLink\u2122 and Zymeworks' Azymetric\u2122 platforms to create a new generation of therapeutics that aim to improve patient outcomes. The company's lead product candidates, including ZW25 and ZW49, are designed to target and disrupt cancer cell growth by engaging the immune system while minimizing off-target effects. Zymeworks is committed to advancing its pipeline through innovative science and strategic partnerships, aiming to enhance the therapeutic landscape in oncology. The company is also focused on developing its proprietary technology platforms to support collaboration with other biopharmaceutical companies, providing tailored solutions for a wide range of diseases. With a strong emphasis on research and development, Zymeworks is poised to make significant strides in the fight against cancer, driven by its mission to deliver transformative therapies to patients in need.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Vancouver, British Columbia, Canada",
    "founded": "2003",
    "website": "https://www.zymeworks.com",
    "ceo": "Ali Tehrani",
    "social_media": {
        "twitter": "https://twitter.com/Zymeworks",
        "linkedin": "https://www.linkedin.com/company/zymeworks/"
    },
    "investor_relations": "https://investors.zymeworks.com",
    "key_executives": [
        {
            "name": "Ali Tehrani",
            "position": "CEO"
        },
        {
            "name": "Duncan Lee",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "ZW25",
                "ZW49"
            ]
        }
    ],
    "seo": {
        "meta_title": "Zymeworks Inc. | Innovative Therapeutics for Cancer Treatment",
        "meta_description": "Explore Zymeworks Inc., a biopharmaceutical company focused on developing innovative therapies for cancer and serious diseases. Learn about their lead candidates and technology platforms.",
        "keywords": [
            "Zymeworks",
            "Biotechnology",
            "Cancer Treatment",
            "ZW25",
            "ZW49",
            "Pharmaceuticals"
        ]
    },
    "faq": [
        {
            "question": "What is Zymeworks known for?",
            "answer": "Zymeworks is known for developing multifunctional therapeutics for cancer treatment."
        },
        {
            "question": "Who is the CEO of Zymeworks?",
            "answer": "Ali Tehrani is the CEO of Zymeworks Inc."
        },
        {
            "question": "Where is Zymeworks headquartered?",
            "answer": "Zymeworks is headquartered in Vancouver, British Columbia, Canada."
        },
        {
            "question": "What are Zymeworks' main products?",
            "answer": "Zymeworks' main products include ZW25 and ZW49."
        },
        {
            "question": "When was Zymeworks founded?",
            "answer": "Zymeworks was founded in 2003."
        }
    ],
    "competitors": [
        "BMY",
        "NVS",
        "REGN",
        "AMGN"
    ],
    "related_stocks": [
        "MRNA",
        "GILD",
        "PFE",
        "JNJ"
    ]
}